Open surgery for radical hysterectomy offers early-stage cervical cancer patients a lower recurrence rate and a higher disease-free survival rate at 4.5 years than a minimally invasive surgical approach, according to the ...
Mar 25, 2022
0
4
For patients with previously untreated metastatic or unresectable melanoma, the combination of relatlimab + nivolumab continues to demonstrate a progression-free survival (PFS) benefit over nivolumab alone, according to updated ...
Mar 21, 2022
0
13
Results from the ZUMA-12 trial led by researchers at The University of Texas MD Anderson Cancer Center showed that first-line treatment with axicabtagene ciloleucel (axi-cel), a chimeric antigen receptor (CAR) T cell therapy, ...
Mar 21, 2022
0
44
The results from the major phase III OlympiA trial shows the drug improves survival rates in women who have inherited faults in their BRCA1 or BRCA2 genes.
Mar 17, 2022
0
23
Cancers are generally harder to treat when they spread rapidly, but clarifying the molecular basis of such aggressive malignancies might in the future lead to new drugs for treating these tumors. Researchers at the Weizmann ...
Feb 22, 2022
0
90
(HealthDay)—Centers that meet the Society for Vascular Surgery (SVS) guidelines for elective open aortic abdominal aneurysm (AAA) repair are associated with improved patient survival, with surgeon volume confounding results, ...
Feb 18, 2022
0
2
Findings from a new study led by Yale Cancer Center researchers show enfortumab vedotin is effective in patients with muscle-invasive bladder cancer (MIBC) not eligible for cisplatin chemotherapy. The data is from Cohort ...
Feb 14, 2022
0
24
(HealthDay)—For patients with recurrent cervical cancer after first-line platinum-containing chemotherapy, survival is significantly longer with cemiplimab than with single-agent chemotherapy, according to a study published ...
Feb 11, 2022
0
1
Researchers led by bioengineers at the University of California San Diego have identified and characterized a previously unrecognized key player in cancer evolution: clusters of mutations occurring at certain regions of the ...
Feb 9, 2022
0
39
Researchers at the University of Toronto and University Health Network have shown how probiotic bacteria in the gut could undermine immunity in pancreatic cancer, pointing toward more personalized cancer treatments.
Feb 8, 2022
0
263
